Aardvark Therapeutics Balance Sheet (2024-2026) | AARD

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 61.64M151.30M141.80M126.40M47.05M91.20M
Short-term Investments (Quarter) 12.02M124.76M115.82M87.06M62.98M28.76M
Cash & Current Investments (Quarter) 73.66M276.06M257.62M213.47M110.03M119.96M
Receivables (Quarter) 1.40M1.40M1.40M
Prepaid Assets (Quarter) 0.47M3.29M2.95M2.86M1.86M2.38M
Current Assets (Quarter) 74.14M154.55M144.77M129.21M111.89M93.58M
Non-Current Assets
Other Non-Current Assets (Quarter) 2.63M1.84M2.19M3.58M4.94M4.74M
Non-Current Assets (Quarter) 3.37M2.47M2.71M4.02M5.29M5.01M
Assets (Quarter) 77.51M157.03M147.47M133.23M117.18M98.59M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 2.30M2.56M5.06M4.44M2.07M4.49M
Payables (Quarter) 2.30M2.56M5.06M4.44M2.07M4.49M
Accumulated Expenses (Quarter) 0.23M3.03M4.84M2.15M8.04M6.78M
Other Accumulated Expenses (Quarter) 0.17M0.64M0.31M0.32M0.42M0.76M
Current Leases (Quarter) 0.34M0.39M0.42M0.43M0.44M0.34M
Total Current Liabilities (Quarter) 4.93M5.98M10.31M10.74M10.55M11.60M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 43.90M126.84M126.76M126.76M
Operating Leases (Quarter) 0.44M0.34M0.23M0.12M
Other Non-Current Liabilities (Quarter) 0.03M0.02M0.01M
Total Non-Current Liabilities (Quarter) 5.37M6.31M10.54M10.85M10.55M
Total Liabilities (Quarter) 5.39M6.34M10.55M10.85M10.55M11.60M
Shareholder's Equity
Common Equity (Quarter) -36.91M-42.31M-46.17M-54.64M150.69M136.93M122.38M106.63M86.99M
Liabilities and Shareholders Equity (Quarter) 77.51M157.03M147.47M133.23M117.18M98.59M
Retained Earnings (Quarter) 0.04M-0.00M0.08M0.08M-137.51M
Treasury Shares (Quarter) 48.91M96.94M96.94M96.94M